Results 221 to 230 of about 2,594,206 (301)

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

open access: yesMolecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad   +35 more
wiley   +1 more source

TREX1, a predator for treating MSI‐H tumors?

open access: yesMolecular Oncology, EarlyView.
Immunotherapy benefits many patients; yet, some with MSI‐H tumors remain unresponsive despite their high immunogenicity. Xu et al. reveal that TREX1 enables immune evasion by degrading cytosolic DNA and suppressing cGAS–STING–IFN‐I signaling. TREX1 loss restores DNA sensing, increases CD8+ T and NK cell infiltration, and boosts antitumor immunity ...
Elena Benidovskaya   +2 more
wiley   +1 more source

Excluded by design: a qualitative study of inequalities in health and social care innovation. [PDF]

open access: yesInt J Equity Health
Tooman TR   +13 more
europepmc   +1 more source

Supporting the professional development of trial managers: how can you help? [PDF]

open access: yesTrials
Mitchell EJ   +10 more
europepmc   +1 more source

Stepped rehabilitation of people with persistent shoulder pain in New Zealand (StePS-NZ): a randomised clinical trial protocol. [PDF]

open access: yesTrials
Sole G   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy